Diane Havard

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

Philip M. Bath, Lisa J Woodhouse, Jason P. Appleton et al. · The Lancet · 2017 · 180 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage

Rustam Al‐Shahi Salman, Martin Dennis, Peter Sandercock et al. · JAMA Neurology · 2021 · 48 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053)

Jason P. Appleton, Polly Scutt, Mark Dixon et al. · International Journal of Stroke · 2017 · 26 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial

Michael Desborough, Rustam Al‐Shahi Salman, Simon Stanworth et al. · The Lancet Neurology · 2023 · 24 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT

Philip M. Bath, Lisa J Woodhouse, Jason P. Appleton et al. · Health Technology Assessment · 2018 · 15 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17